🇧🇷 CATUMAXOMAB in Brazil

CATUMAXOMAB (CATUMAXOMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

CATUMAXOMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is CATUMAXOMAB approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for CATUMAXOMAB in Brazil?

Marketing authorisation holder not available in our data.